loadpatents
name:-0.017771005630493
name:-0.010555982589722
name:-0.011162996292114
O'RIORDAN; Catherine Patent Filings

O'RIORDAN; Catherine

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'RIORDAN; Catherine.The latest application filed is for "gene therapy for retinitis pigmentosa".

Company Profile
10.11.15
  • O'RIORDAN; Catherine - Bridgewater NJ
  • O'Riordan; Catherine - Cambridge MA
  • O'Riordan; Catherine - Waban MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gene Therapy For Retinitis Pigmentosa
App 20220054657 - O'RIORDAN; Catherine ;   et al.
2022-02-24
Gene therapy for retinitis pigmentosa
Grant 11,103,598 - O'Riordan , et al. August 31, 2
2021-08-31
Modified Adeno-associated Viral Capsid Proteins For Ocular Gene Therapy And Methods Of Use Thereof
App 20210261625 - Frederick; Amy ;   et al.
2021-08-26
VARIANT RNAi
App 20210047641 - STANEK; Lisa M. ;   et al.
2021-02-18
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
Grant 10,920,245 - O'Riordan , et al. February 16, 2
2021-02-16
Methods For Detecting Aav
App 20210041451 - JIN; Xiaoying ;   et al.
2021-02-11
Gene Therapy For Spinal Cord Disorders
App 20210008227 - DODGE; James ;   et al.
2021-01-14
Variant RNAi
Grant 10,760,079 - Stanek , et al. Sep
2020-09-01
Gene therapy for spinal cord disorders
Grant 10,744,210 - Dodge , et al. A
2020-08-18
VARIANT RNAi
App 20200109401 - STANEK; Lisa M. ;   et al.
2020-04-09
Gene Therapy For Amyotrophic Lateral Sclerosis And Other Spinal Cord Disorders
App 20200101138 - DODGE; James ;   et al.
2020-04-02
Gene Therapy For Retinitis Pigmentosa
App 20200046851 - O'RIORDAN; Catherine ;   et al.
2020-02-13
Variant RNAi
Grant 10,450,563 - Stanek , et al. Oc
2019-10-22
Gene therapy for retinitis pigmentosa
Grant 10,383,953 - O'Riordan , et al. A
2019-08-20
Gene Therapy For Amyotrophic Lateral Sclerosis And Other Spinal Cord Disorders
App 20180230490 - O'RIORDAN; Catherine ;   et al.
2018-08-16
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
Grant 9,890,394 - O'Riordan , et al. February 13, 2
2018-02-13
VARIANT RNAi
App 20180023082 - STANEK; Lisa M. ;   et al.
2018-01-25
Gene Therapy For Retinitis Pigmentosa
App 20170173183 - O'RIORDAN; Catherine ;   et al.
2017-06-22
Gene Therapy For Amyotrophic Lateral Sclerosis And Other Spinal Cord Disorders
App 20160067312 - DODGE; James ;   et al.
2016-03-10
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
Grant 9,034,836 - Dodge , et al. May 19, 2
2015-05-19
Gene Therapy For Amyotrophic Lateral Sclerosis And Other Spinal Cord Disorders
App 20100267812 - Dodge; James ;   et al.
2010-10-21
Gene Therapy For Amyotrophic Lateral Sclerosis And Other Spinal Cord Disorders
App 20090286857 - O'Riordan; Catherine ;   et al.
2009-11-19
Gene Therapy For Spinal Cord Disorders
App 20090069261 - Dodge; James ;   et al.
2009-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed